Company intelligence / Profile preview

BioResources International

Durham, North Carolina, United Statesmiraculin.com ↗

Ownership: Private
Development stage: Commercial

Overview

Developed high-performance enzyme products that improve the nutritional value of animal feeds. Products are used commercially in global poultry and swine industries. The company was acquired by Novus International in March 2024.

Therapeutic areas: Other
Modalities: Enzymes (feed additives)
Industry: Agriculture & AgTech

Drug pipeline

3 assets

5-hydroxytryptophan

Commercial

Indications: Depression, Weight loss

2 more assets in the full pipeline.

Request access →

Partnerships

Novus International, Inc.

Beyond the preview

Go deeper on BioResources International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioResources International.

Explore the full profile